News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioPorto Receives Intention To Grant For NGAL Exclusion Patent In Europe



2/21/2014 8:36:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The European Patent Office has published intention to grant BioPorto’s patent no. EP2064553 regarding exclusion of acute kidney injury. The patent is part of BioPorto’s IP rights in the NGAL area and is complementary to the NGAL cutoff patent.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES